With a market capitalization (market cap) of $1.75B — a measure of how much the company is worth — ANI Pharmaceuticals, Inc. is the 2201st most valuable company in Healthcare as of August 18, 2026. Shares trade at $76.87, up +1.14% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Visit websiteAs of August 18, 2026, ANI Pharmaceuticals, Inc. (ANIP) is worth $1.75B — this is its market capitalization, the total value of all its outstanding shares.
ANI Pharmaceuticals, Inc.’s market cap is $1.75B, which ranks it #2201 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
ANI Pharmaceuticals, Inc. (ANIP) shares trade at $76.87, up 1.14% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025
ANI Pharmaceuticals, Inc. trades at a price-to-earnings (P/E) ratio of 22.0, based on its latest share price and annual earnings per share.